منابع مشابه
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). This review includes new information on the growing USA overdose epidemic, eight new epidemiologic studies of hypnotics' mortality no...
متن کاملsecuritization of mortality risks in life annuities
insurers have in the past few decades faced longevity risks - the risk that annuitants survive more than expected - and therefore need a new approach to manage this new risk. in this dissertation we survey methods that hedge longevity risks. these methods use securitization to manage risk, so using modern financial and insurance pricing models, especially wang transform and actuarial concepts, ...
15 صفحه اولCarotid stent cell design: lack of benefit or lack of evidence?
Carotid Stent Cell Design: Lack of Benefit or Lack of Evidence? To the Editor: We would like to congratulate Schillinger and colleagues for their recent retrospective analysis on 1684 patients who underwent carotid stenting with either a closedor open-cell stent design.1 The authors concluded that current data do not support the superiority of a specific carotid stent cell design.1 Although we ...
متن کاملExperimental therapy of epilepsy with transcranial magnetic stimulation: lack of additional benefit with prolonged treatment.
OBJECTIVE To investigate the effect of three months of low-frequency repetitive transcranial magnetic stimulation (rTMS) treatment in intractable epilepsy. METHODS Five patients (four males, one female; ages 6 to 50 years), were enrolled in the study; their epilepsy could not be controlled by medical treatment and surgery was not indicated. rTMS was performed twice a week for three months; pa...
متن کاملExtended Mortality Benefit of Early Postinfarction Reperfusion
Background—Reperfusion therapy for myocardial infarction, understood to reduce mortality by preserving left ventricular function, was initially expected to provide increasing benefits over time. Surprisingly, large controlled thrombolysis trials demonstrated maximum benefit at 4 to 6 weeks with no subsequent increased treatment advantage. Such studies, however, compared groups by assigned treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2008
ISSN: 0085-2538
DOI: 10.1038/ki.2008.46